With extensive expertise in this highly specialized field, Noble Life Sciences provides customized biomarker services. Noble scientists have created a process for selection and validation of fit-for-purpose biomarkers.


  • Biomarker discovery
  • Biomarker “fit for purpose” validation with Molecular Tumor Profiling
  • Drug/biomarker pairing and validation studies
  • Clinical Biomarker Development & Implementation
  • Extensive preclinical drug development including PK/PD modeling and efficacy studies

Molecular Tumor Profiling

Noble’s scientific team combines a deep understanding of cancer signaling pathways with public and proprietary genomic data across a compendium of cell lines and clinical samples to identify and validate biomarkers of drug response.

>> Molecular Tumor Profiling

Noble Expertise

Noble’s scientists have decades of experience in preclinical discovery and development of novel therapeutics with deep expertise in biomarker research and validation, including the design of biomarker-driven clinical development strategies.

As former drug developers who know firsthand how frustrating it is to wind up with results that deliver more questions than answers, we take the time to understand your goals and assist you in developing the right plan to provide results that are both accurate–and meaningful.

Why Noble

  • A world-class staff with proven experience in translational and personalized medicine development
  • OncoDiversity™ Cell Line Panel for biomarker and drug candidate characterization
  • Extensive collection of biomarker data and data-mining expertise
  • Standardized biomarker validation process for transition of biomarkers to clinical studies